{
  "anumber": "A28701414",
  "id": "A28701414_0021",
  "page_index": 21,
  "resources": {
    "full_jpg": "https://dctn4zjpwgdwdiiy5odjv7o2se0bqgjb.lambda-url.us-east-1.on.aws/iiif/3/og-2023-kc-nara_A28701414_0021/full/max/0/default.jpg"
  },
  "fields": {
    "doctype": {
      "ms_doctype_v1": "form"
    },
    "years": {
      "ms_years_nlp_v1": [
        2023
      ]
    }
  },
  "is_g325a": false,
  "is_cert_naturalization": false,
  "full_text": "OM Screened by NARA, 6/8/2023 NIJO JANI SERODIAGNOSIS OF ACUTE VIRAL HEPATITIS Test result: HBSA HBcAb|HAV-lgM Interpretation: + Recent acute hepatitis A infection APSTO Early acute type B hepatitis Acute or chronic type B hepatitis Chronic or acute type 8 hepatitis Recovery from or past Infection of type B nepatitis Remote past infection or immediate recovery phase or low level carrier of type B hepatitis MMI Remote past infection or immunization with HBSAg Recent probable hepatitis A infection and probable chronic type B hepatitis Possible non-A non-8 hepatitis infection, other viral infection, or liver toxin ANTI-NUCLEAR ANTIBODY, SERUM Four distinguishable patterns of nuclear fluorescence have been described. The following table indicates the pattern, the antigen associated with the pattern of flourescence, and the incidence of disease; systemic lupus erythematosus (SLE), mixed connective tissue disease (MCTD), rheumatoid arthritis (RA), chronic active hepatitis (CAH), progressive systemic sclerosis (PSS), and normals. INCIDENCE (PERCENT) Pattern Antigen SLE MCTD RA CAH PSS Normal Peripheral (rim) SSDNA 90 20-60 20-60 dsDNA 40-60 3-9 1% Diffuse (homogeneous) dRNP 98 15-40 40 15-40 Speckied RNP 50 100 1% SM 30 1% Nucleolar RNA 20"
}